BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2849270)

  • 1. [Monoclonal antibodies distinguishing human small cell lung cancer from non-small cell lung cancer].
    Ge XR; Wang J; Che YF; Tong CA; Shu LZ; Zhang TM; Lo JM
    Shi Yan Sheng Wu Xue Bao; 1988 Jun; 21(2):251-5. PubMed ID: 2849270
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibody that distinguishes small-cell lung cancer from non-small-cell lung cancer.
    Watanabe J; Okabe T; Fujisawa M; Takaku F; Hirohashi S; Shimosato Y
    Cancer Res; 1987 Feb; 47(3):826-9. PubMed ID: 3026618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination of human small cell and non-small cell lung tumors by a panel of monoclonal antibodies.
    Tong AW; Lee JC; Stone MJ
    J Natl Cancer Inst; 1986 Nov; 77(5):1023-33. PubMed ID: 3022055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological, molecular, and clinical markers for the diagnosis and typing of lung cancer.
    Gazdar AF; Mulshine JL; Kramer BS
    Immunol Ser; 1990; 53():453-68. PubMed ID: 1966068
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of the embryonal neural cell adhesion molecule N-CAM in lung carcinoma. Diagnostic usefulness of monoclonal antibody 735 for the distinction between small cell lung cancer and non-small cell lung cancer.
    Kibbelaar RE; Moolenaar CE; Michalides RJ; Bitter-Suermann D; Addis BJ; Mooi WJ
    J Pathol; 1989 Sep; 159(1):23-8. PubMed ID: 2478684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monoclonal antibodies to lung cancer antigens (a review of the literature)].
    Tkacheva GA
    Med Radiol (Mosk); 1989 May; 34(5):62-75. PubMed ID: 2542715
    [No Abstract]   [Full Text] [Related]  

  • 7. The immunodiagnosis of lung cancer with monoclonal antibodies.
    Egri G; Takáts A
    Med Sci Monit; 2005 Sep; 11(9):RA296-300. PubMed ID: 16127376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of lung cancer in clinical specimens using a human monoclonal antibody HB4C5-clone 3.
    Hirose H; Sato S; Tai H; Okano H; Yasumoto K; Murakami H; Nomoto K; Matsuyama M; Tamaki S; Hashizume S
    Hum Antibodies Hybridomas; 1991 Oct; 2(4):200-6. PubMed ID: 1661189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monoclonal antibodies to human small-cell lung cancer].
    Goncharskaia MA; Rutkevich IM; Tonevitskiĭ AG; Orel NF; Vasil'ev AV; Perevodchikova NI; Mechetner EB
    Biull Eksp Biol Med; 1991 Sep; 112(9):282-5. PubMed ID: 1660741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and treatment of N2 lung carcinoma].
    Hu HC; Guo ZF
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):42-5. PubMed ID: 2848636
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of Cyfra 21-1 as a marker for lung cancer.
    Najemnik C; Mohn-Staudner A; Vetter H; Kokron O; Baumgartner G; Scheiner W; Zwick H; Koderhold G; Alth G; Dudczak R
    Wien Klin Wochenschr; 1996; 108(15):467-72. PubMed ID: 8806188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cyfra 21-1--a new tumor marker of the cytokeratin series in differential diagnosis of lung diseases].
    Oremek GM; Seiffert UB; Siekmeier R; Kirsten R
    Med Klin (Munich); 1995 Jan; 90(1):23-6. PubMed ID: 7533887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of monoclonal antibodies for immunodiagnosis of lung cancer].
    Romanova RI; Gergert VI; Filippov VP; Goncharskaia MA; Evgushchenko GV; Sidorova NF; Gorelova LA
    Probl Tuberk; 1997; (5):44-8. PubMed ID: 9454255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytologic features useful for distinguishing small cell from non-small cell carcinoma in bronchial brush and wash specimens.
    Sturgis CD; Nassar DL; D'Antonio JA; Raab SS
    Am J Clin Pathol; 2000 Aug; 114(2):197-202. PubMed ID: 10941334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular staging and the selection of therapy for non-small cell lung cancer.
    D'Amico TA
    Semin Thorac Cardiovasc Surg; 2005; 17(3):180-5. PubMed ID: 16253819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic use of monoclonal antibodies against small cell lung carcinoma cells.
    De Leij L; Postmus P; Hirschler T; Poppema S; Elema JD; The TH
    Neth J Med; 1985; 28(3):119-23. PubMed ID: 2984592
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical snapshot: lung cancer.
    Chiramannil A
    Am J Nurs; 1998 Apr; 98(4):46-7. PubMed ID: 9556684
    [No Abstract]   [Full Text] [Related]  

  • 18. Pro-gastrin-releasing peptide (Pro-GRP), a tumor marker for small cell lung cancer.
    Oremek GM; Sapoutzis N
    Anticancer Res; 2003; 23(2A):895-8. PubMed ID: 12820319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First advances in decades in lung cancer care.
    Johns Hopkins Med Lett Health After 50; 2005 Oct; 17(8):4-5. PubMed ID: 16247864
    [No Abstract]   [Full Text] [Related]  

  • 20. [Circulating antineuronal antibodies--use of a paraneoplastic phenomenon as tumor marker in small cell bronchial carcinoma].
    Popp W; Drlicek M; Grisold W; Zwick H
    Prax Klin Pneumol; 1988 Aug; 42(8):665-7. PubMed ID: 2845382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.